Screener
ANI Pharmaceuticals ANIP Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Principal payments on borrowings | (8,125) | (4,062) |
| Series A convertible preferred stock dividends paid | — | (813) |
| Proceeds from stock option exercises and ESPP purchases | 2,510 | 3,776 |
| Treasury stock purchases for restricted stock vests | (20,568) | (10,554) |
| Payment of Novitium Contingent Consideration | (80) | — |
| Net Cash and Cash Equivalents Used in Financing Activities | (26,263) | (11,653) |
| Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash | 223 | 544 |
| Net Change in Cash, Cash Equivalents, and Restricted Cash | 74,626 | 72,939 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's share buybacks?
- ANI Pharmaceuticals (ANIP) reported share buybacks of $813K in Q2 2026.
- How has ANI Pharmaceuticals's share buybacks changed year-over-year?
- ANI Pharmaceuticals's share buybacks increased by 47.5% year-over-year, from $551K to $813K.
- What is the long-term trend for ANI Pharmaceuticals's share buybacks?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's share buybacks has grown at a 92.5% compound annual growth rate (CAGR), from $890K to $12.21M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about ANI Pharmaceuticals's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude